Alkermes Plc (ALKS)
29.60
+0.24
(+0.80%)
USD |
NASDAQ |
Jan 08, 16:00
29.60
0.00 (0.00%)
After-Hours: 19:51
Alkermes Research and Development Expense (Annual): 239.63M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Avadel Pharmaceuticals Plc | 15.20M |
| CorMedix, Inc. | 3.942M |
| Jazz Pharmaceuticals Plc | 884.00M |
| Amarin Corp. Plc | 17.86M |
| Perrigo Co. Plc | 112.20M |